Connect with us

Hi, what are you looking for?


CoronaVac approved for use by seniors amid supply issues

HEALTH authorities on Wednesday approved the use of CoronaVac, the vaccine made by China’s Sinovac Biotech Ltd., for the elderly amid global supply problems.

This as the Department of Health reported 6,414 coronavirus infections on Wednesday, bringing the total to 819,164. The death toll increased by 242 to 14,059, while recoveries increased by 163 to 646,404, it said in a bulletin.

There were 158,701 active cases, 97.5% of which were mild, 1.2% did not show symptoms, 0.5% were critical, 0.5% were severe and 0.3% moderate.

“After considering the recommendation of the experts and the current situation of high COVID-19 transmission and limited available vaccines, the Food and Drug Administration (FDA) is allowing the use of Sinovac on senior citizens,” FDA Director General Domingo said in a statement.

“Vaccination should be preceded by an evaluation of the person’s health status and exposure risk to assure that benefits of vaccination outweigh risks,” he added.

FDA and the Department of Health said the benefits of using the vaccine for seniors outweigh the risks. More scientific data on use for senior citizens may soon become available.

DoH and FDA issued the approval upon the recommendation of the Vaccine Expert Panel from the Science and Technology department.

“The Vaccine Expert Panel thoroughly discussed the matter amid the current vaccine supply in the country and we hope that this would address the present demand for vaccines,” presidential spokesman Herminio L. Roque, Jr. said in a statement on Wednesday.

The FDA earlier refused to recommend the use of CoronaVac for seniors supposedly due to a lack of concrete studies.

Nina G. Gloriani, chief of the Science and Technology department’s vaccine development panel, said the body had recommended the use of the drug for the elderly because it was safe to use.  

Citing clinical trials of CoronaVac in Brazil and China that included 400 and 422 senior citizens, respectively, Ms. Gloriani said the patients only exhibited mild to moderate side effects after taking the shot.

“It’s safety profile is good,” she told a televised news briefing in Filipino. “The side effects were mild to moderate,” she said, adding that patients only experienced pain in the injection area for two days, as well as headaches.

The vaccine was being used by China and Indonesia to inoculate their seniors, she said.

Ms. Gloriani said the panel made the recommendation amid a shortage in supply of vaccines made by British drug maker AstraZeneca Plc that were being used to vaccinate old people.

“We are in a pandemic and we can’t afford the delay because the vaccines that we ordered have not arrived,” she said. “We want to use whatever we have.”

Vaccine czar Carlito G. Galvez, Jr. on Tuesday said the Philippines would take delivery of about 1.5 million more doses of CoronaVac this month.

The Philippines initially expected to receive four million doses of vaccines this month but the target delivery was trimmed to just two million due to global supply problems.

He said the government was using diplomatic channels to ensure access to almost a million more doses from AstraZeneca.

Ms. Gloriani said the vaccine developed by Russia’s Gamaleya Institute could also be used on seniors. Sputnik V is 92% effective among the elderly, she said, citing an evaluation by the panel.

More than 854,000 Filipinos have been vaccinated against the coronavirus as of April 5, Mr. Galvez said. — Vann Marlo M. Villegas and Kyle Aristophere T. Atienza

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



Virgin Orbit’s next satellite launch will take place from the UK, following the success of the “Straight Up” mission, which lifted off from Mojave...


Post Office collection and cash delivery workers are to stage a one-day strike later this month in a dispute over pay. Members of the...


UK consumers cut back on credit card borrowing in May amid fears over rising interest rates and a slowing economy driven by a cost...


London City airport is seeking to overturn its Saturday flight ban and raise by 40% the limit on its passenger numbers. A local residents’...


The bank said that it was introducing a £1,200-a-year pay increase from August 1, which would start to show in next month’s pay packets....


Postmasters caught up in the Horizon IT scandal say that they are still being “left in the dark” about a compensation package after the...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...


As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.